FineHeart secures 83 million euros to advance the development of cardiac devices

FineHeart has raised €83 million ($96.6 million) in public and private funding to advance the development of its implantable cardiac output accelerator for the advanced treatment of heart failure. The French company’s main clinical-stage product in development is Flowmaker, a…











